Abnormalities in coagulatory parameters have been observed in many COVID-19 patients, including increased levels of D-dimer, increased concentrations of fibrinogen and prolonged prothrombin times (PTs), thrombotin times (TTs), and activated partial thromboplastin times (APTTs) [7,11,12]. The gene discussed is F2; the disease is COVID-19.